Mission Product Holdings
Private Equity Round in 2022
Mission Product Holdings, Inc. specializes in manufacturing and distributing athletic and performance apparel and accessories for men and women. Founded in 2007 and headquartered in New York, the company offers a wide range of products including t-shirts, tank tops, jackets, shorts, leggings, and cooling towels. It is particularly known for its innovative thermo-regulation technology, which is designed to control body temperature and enhance athletic performance during training and competition. The company markets its products under various brand names, including HydroActive MAX and Vaporactive, and provides these offerings through online retail channels. With a focus on developing lightweight and proprietary fabrics, Mission Product Holdings aims to deliver effective cooling solutions for sports, outdoor activities, and job site applications.
Coop Home Goods
Private Equity Round in 2021
Coop Home Goods is a manufacturer that specializes in bedding products designed to enhance the sleeping experience. The company offers a diverse range of items, including adjustable pillows, comforters, mattress pads and protectors, bedding sets, pet beds, and various pillow accessories. Coop Home Goods focuses on creating adjustable pillows that accommodate different body types and sleep positions by allowing users to customize the fill, ensuring proper alignment and comfort. Their products are made from breathable materials to promote airflow, contributing to a functional and comfortable sleep environment. Customer inquiries are managed through phone, email, and online applications, reflecting the company's commitment to customer service.
SportPet Designs
Private Equity Round in 2021
SportPet Designs is a well-established manufacturer and marketer of a wide range of pet products, including branded and private label items. The company specializes in creating furniture, scratchers, beds, and toys for pets, offering a diverse selection that caters to the needs of both dogs and cats. Its product line includes elevated dog beds, deluxe mattress beds, cat carriers, and luxury sofa beds, all designed to ensure comfort and safety for pets. SportPet Designs is committed to providing high-quality, environmentally responsible products, making it a trusted choice for pet owners seeking durable and stylish solutions for their animals.
reCommerce
Venture Round in 2020
reCommerce is a full-service brand agency that assists international brands in optimizing their Amazon presence and increasing sales.
Codagenix
Series B in 2020
Codagenix Inc., established in 2009 and headquartered in Farmingdale, New York, specializes in developing live-attenuated viral vaccines using its proprietary Synthetic Attenuated Virus Engineering (SAVE) platform. This technology involves the rational design of entire viral genomes via synthetic biology to create safe and effective vaccines for various human diseases such as influenza, dengue, respiratory syncytial virus, polio, and others. Additionally, Codagenix offers agricultural and companion animal vaccines.
PMV Pharmaceuticals
Series C in 2019
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.
JD Beauty
Acquisition in 2019
JD Beauty Group is the perfect company to ensure that you are on the top of your beauty products game. Their product quality, selection, diversity, and prices are the best in the industry. They are commited to using only the best materials in concert with the finest craftsmanship.
Japonesque
Acquisition in 2019
Japonesque LLC is a beauty care company based in San Ramon, California, specializing in high-quality cosmetics and professional beauty tools. Founded in 1984, Japonesque draws inspiration from the traditional makeup techniques of Kabuki theater in Japan, offering a product range that includes makeup brushes, eyelash curlers, nail care tools, and cosmetics designed for both professionals and beauty enthusiasts. The company’s offerings feature innovative formulations and luxurious packaging, catering to the needs of discerning customers seeking both performance and aesthetic appeal. Japonesque products are available through various retail channels in the United States, as well as beauty supply stores, salons, and spas worldwide, ensuring accessibility for a global clientele.
SetPoint Medical
Venture Round in 2019
SetPoint Medical Corporation is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices for the treatment of debilitating inflammatory diseases. Established in 2006 and formerly known as Innovative Metabolics Inc., the company aims to provide innovative solutions for chronic autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. SetPoint Medical's technology leverages vagus nerve stimulation to activate the body's natural inflammatory reflex, producing a systemic anti-inflammatory effect. This platform offers an alternative treatment option that may present lower risks and costs compared to traditional drug therapies, ultimately seeking to improve patient outcomes in managing chronic inflammatory diseases.
ORIC Pharmaceuticals
Series D in 2019
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.
Celmatix
Venture Round in 2019
Celmatix Inc. is a personalized medicine company dedicated to advancing women's health, particularly in the areas of reproductive health and fertility. Founded in 2009 and based in New York, the company has developed innovative solutions such as POLARIS, a web-based analytics platform that assesses a woman's likelihood of success with various fertility treatments based on her clinical metrics. Additionally, Celmatix offers NOVA, a patient portal designed to enhance the patient experience within clinics. By leveraging predictive analytics and genomics, the company enables women to make informed decisions regarding their fertility while equipping healthcare providers with data-driven tools for improved patient care. Celmatix has also established a strategic alliance with Evotec to further its research and development endeavors.
Peloton Therapeutics
Series E in 2019
Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Dallas, Texas, dedicated to developing innovative medicines for patients with cancer and other serious conditions. The company focuses on targeting HIF-2a, a transcription factor previously considered difficult to address with small molecules. Its lead drug candidate, PT2977, is an oral HIF-2a inhibitor currently undergoing Phase 2 clinical trials for advanced or metastatic clear cell renal cell carcinoma, and it is being evaluated in various settings, including in patients with von Hippel-Lindau disease-associated renal cell carcinoma and in combination with cabozantinib. Additionally, Peloton is advancing PT2567, another oral HIF-2a inhibitor in preclinical development for non-oncology indications such as pulmonary arterial hypertension. Founded in 2010 and previously known as Damascus Pharmaceutics, Peloton Therapeutics aims to leverage its scientific expertise and collaborations to become a leading biotech company in the region.
Constellation Pharmaceuticals
Series F in 2018
Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapeutics for unmet medical needs in cancer treatment. The company specializes in the field of epigenetics, aiming to address cancers associated with abnormal gene expression and drug resistance. Its lead product candidates include CPI-0610, which is undergoing Phase II clinical trials for myelofibrosis in combination with ruxolitinib, and CPI-1205, currently in Phase Ib/II trials for metastatic castration-resistant prostate cancer in conjunction with androgen receptor signaling inhibitors. Additionally, Constellation is developing CPI-0209, which is in the Phase I dose escalation stage of a Phase I/II trial aimed at treating solid tumors. Founded in 2008, the company was previously known as Epigenetix, Inc. before rebranding to its current name in March 2008.
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.
Remedy Health Media
Acquisition in 2017
Remedy Health Media is a digital health platform that provides health-related information to consumers and caregivers in the United States. Established in 1994 and headquartered in New York, the company publishes various health magazines, including Diabetes Focus and MediZine's Healthy Living, as well as digital resources like Healthcommunities.com, which features a symptom checker and expert Q&A. Remedy Health Media aims to empower patients and caregivers by offering accessible content, tools, and authentic community interactions with health professionals. Additionally, it publishes Remedy, which shares insights from health experts, and RemedyKids, focused on children's health information. The company's products and services are designed to help individuals navigate the healthcare landscape more effectively, ultimately contributing to improved health outcomes. Publications are distributed through retail partners, pharmacy counters, and doctors' offices.
Bear Down Brands
Venture Round in 2017
Bear Down Brands is a network of consumer brands that each focus on premium home, health, and personal care products.Bear Down Brands mission is to create elegant, practical, and innovative products that enhance the way you care for yourself and the world around you.Bear Down's focus has been on developing a well-rounded product portfolio while providing advanced product technologies, award-winning customer support, and strong brand relationships with our consumers.
Codagenix
Venture Round in 2017
Codagenix Inc., established in 2009 and headquartered in Farmingdale, New York, specializes in developing live-attenuated viral vaccines using its proprietary Synthetic Attenuated Virus Engineering (SAVE) platform. This technology involves the rational design of entire viral genomes via synthetic biology to create safe and effective vaccines for various human diseases such as influenza, dengue, respiratory syncytial virus, polio, and others. Additionally, Codagenix offers agricultural and companion animal vaccines.
SetPoint Medical
Series D in 2017
SetPoint Medical Corporation is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices for the treatment of debilitating inflammatory diseases. Established in 2006 and formerly known as Innovative Metabolics Inc., the company aims to provide innovative solutions for chronic autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. SetPoint Medical's technology leverages vagus nerve stimulation to activate the body's natural inflammatory reflex, producing a systemic anti-inflammatory effect. This platform offers an alternative treatment option that may present lower risks and costs compared to traditional drug therapies, ultimately seeking to improve patient outcomes in managing chronic inflammatory diseases.
Hubble
Pre Seed Round in 2017
Hubble is a mobile application that facilitates connections among users by enabling them to discover and communicate with like-minded individuals in their local area. The platform is designed to enhance social interaction by allowing users to ask location-based questions and receive answers from nearby individuals, thus providing access to hyperlocal information. This approach helps users save time by eliminating the need to sift through online reviews and websites for relevant insights. Hubble's community-focused model encourages ongoing conversations beyond initial meetups, fostering a network of connections within local communities.
Constellation Pharmaceuticals
Series E in 2017
Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapeutics for unmet medical needs in cancer treatment. The company specializes in the field of epigenetics, aiming to address cancers associated with abnormal gene expression and drug resistance. Its lead product candidates include CPI-0610, which is undergoing Phase II clinical trials for myelofibrosis in combination with ruxolitinib, and CPI-1205, currently in Phase Ib/II trials for metastatic castration-resistant prostate cancer in conjunction with androgen receptor signaling inhibitors. Additionally, Constellation is developing CPI-0209, which is in the Phase I dose escalation stage of a Phase I/II trial aimed at treating solid tumors. Founded in 2008, the company was previously known as Epigenetix, Inc. before rebranding to its current name in March 2008.
PMV Pharmaceuticals
Series B in 2017
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.
Palmetto Moon
Acquisition in 2016
Palmetto Moon, LLC is a retailer specializing in apparel, footwear, and gifts for men, women, and children, with a focus on collegiate, coastal, and southern living. Founded in 2002 and based in Charleston, South Carolina, the company offers a diverse range of products, including T-shirts, jackets, dresses, and various accessories such as wallets, jewelry, and home décor items. Its footwear selection includes boots, sandals, and flip-flops for all ages. Palmetto Moon operates multiple physical store locations across the southeastern United States, including Wilmington, North Carolina, and several cities in South Carolina, while also providing an online shopping platform to reach a broader customer base. The company's commitment to quality and regional themes has established it as a prominent player in the retail market.
Texas Family Fitness
Acquisition in 2016
Texas Family Fitness, LLC is a Coppell, Texas-based business operating family-oriented health and fitness clubs across the Dallas-Fort Worth area, including The Colony, Frisco, Plano, and Allen. The company offers a range of services such as personal training and group fitness classes, utilizing state-of-the-art equipment and knowledgeable staff to create an affordable, family-friendly environment. Unlike competitors, Texas Family Fitness does not charge members for unused amenities, making its family membership plans more cost-effective.
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.
Polder Housewares
Acquisition in 2016
Polder is a manufacturer of housewares products. They offer products that include kitchen, bathroom, laundry, cooking, baking, grilling, sinkware, and storage.
Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease and frontotemporal dementia. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes advanced antibody technology and insights from neuroimmunology and human genetics to create innovative treatments. Alector’s pipeline includes several candidates, such as AL001, which is undergoing phase II clinical trials for frontotemporal dementia, and AL101, currently in phase I trials for Alzheimer's and Parkinson's diseases. Additionally, AL002 and AL003 are in phase 1b trials for Alzheimer’s disease. The company is actively engaged in research and development, with a total of ten programs at various stages. Alector has formed a strategic collaboration with Adimab, LLC to enhance its antibody research and development capabilities, aiming to efficiently generate and validate antibody drugs that target key disease-related mechanisms.
Constellation Pharmaceuticals
Series E in 2015
Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapeutics for unmet medical needs in cancer treatment. The company specializes in the field of epigenetics, aiming to address cancers associated with abnormal gene expression and drug resistance. Its lead product candidates include CPI-0610, which is undergoing Phase II clinical trials for myelofibrosis in combination with ruxolitinib, and CPI-1205, currently in Phase Ib/II trials for metastatic castration-resistant prostate cancer in conjunction with androgen receptor signaling inhibitors. Additionally, Constellation is developing CPI-0209, which is in the Phase I dose escalation stage of a Phase I/II trial aimed at treating solid tumors. Founded in 2008, the company was previously known as Epigenetix, Inc. before rebranding to its current name in March 2008.
ORIC Pharmaceuticals
Series B in 2015
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.
JD Beauty
Acquisition in 2015
JD Beauty Group is the perfect company to ensure that you are on the top of your beauty products game. Their product quality, selection, diversity, and prices are the best in the industry. They are commited to using only the best materials in concert with the finest craftsmanship.
Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease and frontotemporal dementia. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes advanced antibody technology and insights from neuroimmunology and human genetics to create innovative treatments. Alector’s pipeline includes several candidates, such as AL001, which is undergoing phase II clinical trials for frontotemporal dementia, and AL101, currently in phase I trials for Alzheimer's and Parkinson's diseases. Additionally, AL002 and AL003 are in phase 1b trials for Alzheimer’s disease. The company is actively engaged in research and development, with a total of ten programs at various stages. Alector has formed a strategic collaboration with Adimab, LLC to enhance its antibody research and development capabilities, aiming to efficiently generate and validate antibody drugs that target key disease-related mechanisms.
ThermoLift
Venture Round in 2015
ThermoLift, Inc. specializes in the development and manufacture of innovative air conditioning and heat pump systems designed for heating, cooling, and hot water applications. Established in 2012 and headquartered in Stony Brook, New York, the company targets both residential and commercial markets. ThermoLift is focused on creating a transformative thermally driven heat pump that integrates multiple functions into a single device. By leveraging proven technology, the company aims to significantly decrease energy consumption for space conditioning by as much as 50%.
SynchroPET
Debt Financing in 2015
SynchroPET Inc. is a biomedical device company based in Stony Brook, New York, founded in 2013. The company specializes in the development of advanced Positron Emission Tomography (PET) imaging systems designed for both preclinical research and clinical applications. Its product lineup includes the PET/MRI system, which enhances preclinical research capabilities; the Mini-PET, a portable imaging device for laboratory use; the RatCAP, an innovative buoyant PET scanner that allows for unimpeded animal movement during studies; and the Wrist PET Detector, a non-invasive scanner intended for clinical use. SynchroPET’s focus on creating compact and versatile imaging devices aims to improve diagnostic accuracy and treatment options for diseases such as cancer, Alzheimer's, and Parkinson's, ultimately facilitating advancements in personalized medicine.
Codagenix
Series A in 2015
Codagenix Inc., established in 2009 and headquartered in Farmingdale, New York, specializes in developing live-attenuated viral vaccines using its proprietary Synthetic Attenuated Virus Engineering (SAVE) platform. This technology involves the rational design of entire viral genomes via synthetic biology to create safe and effective vaccines for various human diseases such as influenza, dengue, respiratory syncytial virus, polio, and others. Additionally, Codagenix offers agricultural and companion animal vaccines.
NGM Biopharmaceuticals
Series D in 2015
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Incorporated in 2007 and headquartered in South San Francisco, California, the company is engaged in creating novel treatments informed by key biological pathways. Its product candidates include Aldafermin, an engineered variant of the FGF19 hormone currently in Phase 2b clinical trials for non-alcoholic steatohepatitis (NASH), and NGM313, an agonistic antibody in Phase 1b trials for type 2 diabetes and NASH. Other candidates in development include NGM395 for metabolic syndrome, NGM120 to address cancer anorexia/cachexia syndrome, NGM217 aimed at improving insulin production in diabetes patients, and NGM621 to target a protein involved in age-related macular degeneration. NGM Biopharmaceuticals collaborates with Merck Sharp & Dohme Corp. to advance its research and development efforts in creating impactful medicines that enhance patient health.
Codagenix Inc., established in 2009 and headquartered in Farmingdale, New York, specializes in developing live-attenuated viral vaccines using its proprietary Synthetic Attenuated Virus Engineering (SAVE) platform. This technology involves the rational design of entire viral genomes via synthetic biology to create safe and effective vaccines for various human diseases such as influenza, dengue, respiratory syncytial virus, polio, and others. Additionally, Codagenix offers agricultural and companion animal vaccines.
PlayMonster
Acquisition in 2014
PlayMonster is a prominent designer, manufacturer, and marketer of games, children's puzzles, preschool toys, and teaching tools. The company emphasizes innovation and the growth of its diverse brands and product categories, catering to children, adults, and families alike. In addition to producing engaging and educational toys, PlayMonster focuses on delivering creative activities that foster development and learning. Through its commitment to quality and creativity, PlayMonster has established itself as a key player in the toy and game industry.
HCOA Fitness
Acquisition in 2014
HCOA Fitness is a leading fitness center operator in Puerto Rico, managing a total of 18 locations, including both female-only and co-ed gyms, with 15 situated across the island. The company offers a broad range of health and wellness services, featuring state-of-the-art strength and cardiovascular equipment, group exercise and cycling classes, as well as personal training options. HCOA Fitness aims to provide its customers with the necessary resources and support to achieve their fitness goals and maintain healthy lifestyles.
Immune Design
Series C in 2013
Immune Design Corp., a clinical-stage immunotherapy company based in Seattle, Washington, focuses on enabling the body's immune system to combat diseases, with a primary emphasis on cancer treatment. The company leverages its ZVex and GLAAS discovery platforms to develop innovative therapies. Its lead product candidate is G100, currently in Phase II clinical trials for treating follicular non-Hodgkin lymphoma, both as a monotherapy and in combination therapy. Immune Design has collaboration and license agreements with Sanofi Pasteur. The company was founded in 2008 and operates under the umbrella of Merck & Co., Inc.
SetPoint Medical
Series C in 2013
SetPoint Medical Corporation is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices for the treatment of debilitating inflammatory diseases. Established in 2006 and formerly known as Innovative Metabolics Inc., the company aims to provide innovative solutions for chronic autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. SetPoint Medical's technology leverages vagus nerve stimulation to activate the body's natural inflammatory reflex, producing a systemic anti-inflammatory effect. This platform offers an alternative treatment option that may present lower risks and costs compared to traditional drug therapies, ultimately seeking to improve patient outcomes in managing chronic inflammatory diseases.
NGM Biopharmaceuticals
Series C in 2013
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Incorporated in 2007 and headquartered in South San Francisco, California, the company is engaged in creating novel treatments informed by key biological pathways. Its product candidates include Aldafermin, an engineered variant of the FGF19 hormone currently in Phase 2b clinical trials for non-alcoholic steatohepatitis (NASH), and NGM313, an agonistic antibody in Phase 1b trials for type 2 diabetes and NASH. Other candidates in development include NGM395 for metabolic syndrome, NGM120 to address cancer anorexia/cachexia syndrome, NGM217 aimed at improving insulin production in diabetes patients, and NGM621 to target a protein involved in age-related macular degeneration. NGM Biopharmaceuticals collaborates with Merck Sharp & Dohme Corp. to advance its research and development efforts in creating impactful medicines that enhance patient health.
GHS Interactive Security
Acquisition in 2013
Customer safety & satisfaction is their goal, and they are proud to hold an A+ rating by the Better Business Bureau. They value their customers and put their safety at the forefront of everything they do. They do this by not only providing state-of-the-art products & exceptional customer service, but also by maintaining strong relationships with their customers, their families, and their communities. GHS’s valued employees and affiliates operate with a high degree of integrity while working side-by-side with their customers to provide customized integrated solutions to meet their specific home, business, and financial needs.
Brighter Dental Care
Private Equity Round in 2012
Brighter Dental Care is a dental service provider that caters to individuals aged six and above. The company's team consists of general dentists and specialists who focus on specific areas of dentistry. Brighter Dental Care offers a range of services including regular dental checkups and cleanings, x-rays, fillings, sealants, fluorides, orthodontics, teeth whitening, and implants.
Aragon Pharmaceuticals
Series C in 2012
Aragon Pharmaceuticals is a discovery-stage small molecule company dedicated to developing therapeutics for hormone-resistant cancers, specifically targeting prostate and breast cancer. The company specializes in anti-endocrine therapies that leverage nuclear receptor biology, medicinal chemistry, and drug discovery methodologies. Aragon aims to identify and create selective androgen receptor degraders for prostate cancer and selective estrogen receptor degraders for estrogen-sensitive breast cancer, addressing the need for effective treatments in these challenging areas of oncology.
Celmatix Inc. is a personalized medicine company dedicated to advancing women's health, particularly in the areas of reproductive health and fertility. Founded in 2009 and based in New York, the company has developed innovative solutions such as POLARIS, a web-based analytics platform that assesses a woman's likelihood of success with various fertility treatments based on her clinical metrics. Additionally, Celmatix offers NOVA, a patient portal designed to enhance the patient experience within clinics. By leveraging predictive analytics and genomics, the company enables women to make informed decisions regarding their fertility while equipping healthcare providers with data-driven tools for improved patient care. Celmatix has also established a strategic alliance with Evotec to further its research and development endeavors.
Stagnito Business Information
Acquisition in 2012
Stagnito Business Information is the retail industry’s most complete provider of market intelligence and strategic communication resources.
Celmatix Inc. is a personalized medicine company dedicated to advancing women's health, particularly in the areas of reproductive health and fertility. Founded in 2009 and based in New York, the company has developed innovative solutions such as POLARIS, a web-based analytics platform that assesses a woman's likelihood of success with various fertility treatments based on her clinical metrics. Additionally, Celmatix offers NOVA, a patient portal designed to enhance the patient experience within clinics. By leveraging predictive analytics and genomics, the company enables women to make informed decisions regarding their fertility while equipping healthcare providers with data-driven tools for improved patient care. Celmatix has also established a strategic alliance with Evotec to further its research and development endeavors.
2-20 Records Management
Acquisition in 2011
2-20 Records Management, LLC is an information management company based in Edison, New Jersey, offering a comprehensive suite of records storage and management services. These services include document storage, secure shredding, document destruction, data protection, vault storage, and imaging solutions. The company caters to a diverse clientele, including accounting and architectural firms, financial services, government and healthcare organizations, law firms, pharmaceutical companies, as well as small, mid-size, and enterprise businesses. With operations in Arizona, Florida, Southern California, New York, and Pennsylvania, 2-20 Records Management emphasizes a national presence backed by experienced local teams, ensuring compliance-driven and secure record management tailored to the needs of its clients.
Pulse Veterinary Technologies
Acquisition in 2009
Pulse Veterinary Technologies, LLC is a company based in Alpharetta, Georgia, specializing in the development and marketing of non-invasive therapeutic products aimed at treating soft tissue conditions in veterinary medicine. Founded in 2009, the company offers advanced devices such as the VersaTron and VersaTron 4Paws, which are designed to manage musculoskeletal disorders that lead to pain and lameness in horses and dogs. Additionally, Pulse Veterinary Technologies provides ProTec PRP injectable systems for veterinary applications. The company is recognized for its commitment to high standards of quality and innovation in regenerative veterinary medicine, establishing itself as a trusted partner for veterinary professionals worldwide.
Hart Systems
Acquisition in 2009
Hart Systems, LLC specializes in developing cloud-based physical inventory management solutions tailored for the retail industry. The company offers a comprehensive suite of services that includes client support, account management, help desk assistance, and servers and data communications support. Additionally, Hart Systems provides training to ensure that inventory managers and store managers are well-equipped and confident in utilizing their inventory management systems effectively. By focusing on these key areas, Hart Systems aims to enhance operational efficiency and accuracy in inventory management for its clients in the retail sector.
New Whey Nutrition
Acquisition in 2008
New Whey Nutrition company's line of business includes the wholesale distribution of prescription drugs, proprietary drugs, and toiletries.e Company sells a portfolio of functional beverages and other nutritional products through Wal-mart, Kroger, Vitamin Shoppe and a variety of other retailers and distributors. The company’s best-selling product is New Whey Liquid Protein, an innovative, concentrated protein beverage containing 42 grams of protein with no sugar or fat in 3.8 ounces.
Passport Systems
Series C in 2007
Passport Systems Inc. is a company that designs and develops advanced inspection and detection systems aimed at addressing security threats, particularly in the wake of the 9/11 terrorist attacks. Based in Billerica, Massachusetts, and founded in 2002, the company specializes in creating both active and passive solutions for the automatic detection, localization, and identification of concealed threats and contraband. Its notable products include the SmartScan 3D, which is utilized for the automated clearing of cargo while detecting potential threats, and the SmartShield, a networked radiation detection system aimed at monitoring and preventing radiological threats. The technology developed by Passport Systems is implemented in various critical areas such as airports, seaports, and border crossings, enhancing national and international security by facilitating the identification of explosives, contraband, and other hazardous materials. Through its innovative solutions, Passport Systems plays a significant role in improving safety and security at key points in the supply chain industry.
Utrecht
Acquisition in 2007
Utrecht is a specialty retailer focused on providing a wide range of fine art supplies, including paints, paper, canvas, and brushes. The company operates 38 stores across the United States, strategically located near or within prominent colleges and universities, catering to the needs of students and artists. In addition to its physical retail presence, Utrecht also offers a catalogue and an online store, allowing customers to access their products conveniently. The company is known for selling its own brand of art materials, further establishing its position in the art supply market.
Neopolitan Networks
Series A in 2007
Neopolitan Networks, headquartered in Palo Alto, California, serves a broad clientele of small, medium-sized, and large organizations with scalable, flexible, robust networking solutions. They provide organizations with transport, including end-to-end private network solutions, Internet connectivity and robust points-of-presence in our data centers that capitalize on advances in fiber optic and wireless technologies to increase network performance and coverage.
Pionetics
Series C in 2007
Pionetics Corporation is a water technology company based in San Carlos, California, founded in 1995. The company specializes in manufacturing innovative water treatment products designed to produce safe and great-tasting drinking water while minimizing wastewater compared to traditional systems. Pionetics offers a range of products, including water filters, drinking water systems, and water coolers, catering to household, commercial, and industrial applications. In addition to product sales, the company provides installation services and rental options for its drinking water systems. Pionetics distributes its products through authorized dealers both in the United States and internationally. As of 2008, it operates as a subsidiary of Rayne Corporation.
Passport Systems
Series B in 2006
Passport Systems Inc. is a company that designs and develops advanced inspection and detection systems aimed at addressing security threats, particularly in the wake of the 9/11 terrorist attacks. Based in Billerica, Massachusetts, and founded in 2002, the company specializes in creating both active and passive solutions for the automatic detection, localization, and identification of concealed threats and contraband. Its notable products include the SmartScan 3D, which is utilized for the automated clearing of cargo while detecting potential threats, and the SmartShield, a networked radiation detection system aimed at monitoring and preventing radiological threats. The technology developed by Passport Systems is implemented in various critical areas such as airports, seaports, and border crossings, enhancing national and international security by facilitating the identification of explosives, contraband, and other hazardous materials. Through its innovative solutions, Passport Systems plays a significant role in improving safety and security at key points in the supply chain industry.
Moose River Media
Acquisition in 2005
Moose River Media is a publishing company that specializes in print and digital magazines, high-traffic electronic media, custom communications, and proprietary research. It primarily serves the professional lawn and landscape, tree care, light construction, forestry, and agricultural industries across the United States. The company produces a range of publications, including titles such as Farming, Turf, Forest Products Equipment, Superintendent, and Buyer's Guide, catering to the informational needs of its target sectors. Through its diverse media offerings, Moose River Media aims to provide valuable insights and resources for professionals in these industries.
Game Trust
Series B in 2005
Game Trust, Inc. is a company that specializes in providing infrastructure for community and commerce applications within the online gaming and entertainment sectors. Founded in 2002 and headquartered in New York, the company is known for its Game Frame platform, which is designed for online casual games. Game Frame supports the needs of the casual gaming audience by offering a comprehensive online entertainment experience. The platform is licensed by website operators and game developers, enabling them to enhance their offerings with community features and commerce capabilities, whether for new titles or existing games. Game Trust operates in both the United States and Europe, serving a diverse range of game distributors and developers. As of October 2007, Game Trust functions as a subsidiary of RealNetworks, Inc.
Sensicore
Series C in 2005
Sensicore, Inc. is a manufacturer and developer of smart sensor systems and sensor networks, headquartered in Ann Arbor, Michigan. The company specializes in automating water testing, data collection, and analysis for both drinking and industrial applications. Its flagship products include WaterPOINT, a handheld water tester that provides a comprehensive profile of various chemistry measurements, and WaterNOW, a web-based data visualization and decision support system for managing water systems. Sensicore also offers a variety of sensor kits and bundles designed for disinfection and basic water testing, alongside colorimetric test kits that measure a range of water quality parameters. Additionally, the company provides accessories such as portable thermal printers and power supply products to enhance its testing solutions. Sensicore's products serve multiple applications, including monitoring incoming water quality, cooling tower processes, and filtration system performance. Founded in 2000, Sensicore operates as a subsidiary of GE Analytical Instruments, Inc. as of 2008.
ArgiNOx Phamaceuticals
Series C in 2005
Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for the treatment of cardiogenic shocks. Arginox Pharmaceuticals is based in Redwood City, California.
Roche NimbleGen
Series F in 2004
Roche NimbleGen is a biotechnology company headquartered in Madison, Wisconsin, that specializes in providing products and services for the life science research market. The company offers a range of solutions including the SeqCap EZ system, which enhances exome enrichment in a single test tube, as well as various library construction kits and reagents. Roche NimbleGen's SeqCap Epi system focuses on DNA methylation assessment, providing tools for single-base resolution analysis. The company utilizes its proprietary Maskless Array Synthesis technology to manufacture high-density DNA microarrays, improving the quality and yield of DNA sequencing data. Additionally, Roche NimbleGen offers software tools such as SignalMap for genomic data visualization and NimbleDesign for library design, alongside comprehensive online technical support. Established in 1999, Roche NimbleGen operates as a subsidiary of Roche Holding AG, emphasizing research and innovation in genomic technologies.
ArgiNOx Phamaceuticals
Series B in 2004
Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for the treatment of cardiogenic shocks. Arginox Pharmaceuticals is based in Redwood City, California.
Game Trust
Series A in 2003
Game Trust, Inc. is a company that specializes in providing infrastructure for community and commerce applications within the online gaming and entertainment sectors. Founded in 2002 and headquartered in New York, the company is known for its Game Frame platform, which is designed for online casual games. Game Frame supports the needs of the casual gaming audience by offering a comprehensive online entertainment experience. The platform is licensed by website operators and game developers, enabling them to enhance their offerings with community features and commerce capabilities, whether for new titles or existing games. Game Trust operates in both the United States and Europe, serving a diverse range of game distributors and developers. As of October 2007, Game Trust functions as a subsidiary of RealNetworks, Inc.
netomat, Inc. is a New York-based company that specializes in developing websites, applications, and social media services optimized for desktop, tablet, and mobile devices. Founded in 2001, netomat offers a range of solutions including mobile website design, responsive applications, and location-based services. Its enterprise-class Mobility Server allows organizations to publish web content across various mobile devices, enhancing user experience on both high-end and lower-end devices. The company also provides netomat MediaHub, a cloud-based service that facilitates the management and streaming of multimedia content, particularly videos, across mobile and desktop platforms. Additionally, netomat offers professional services such as project management, turnkey mobile software implementation, cloud hosting, and ongoing management, alongside social media integration and analytics. Its diverse clientele includes tourism organizations, sports leagues, gaming companies, and law firms, both in the United States and internationally.
The Tiffen Company
Acquisition in 2003
The Tiffen Company, founded in 1938 by Steve Tiffen, is a manufacturer of imaging accessories tailored for the consumer and professional imaging sectors, including motion picture and broadcast television. Headquartered in Hauppauge, New York, the company specializes in a diverse range of products, such as optical photographic filters, lens accessories, Steadicam camera stabilizing systems, and location lighting equipment. Additionally, Tiffen offers camera bags, digital effects software, teleprompters, tripods, and various support systems. The company is recognized for its commitment to quality and innovation in the imaging industry, providing essential tools that enhance the work of photographers and filmmakers alike.
comScore, Inc. is an information and analytics company that specializes in measuring audiences, consumer behavior, and advertising across various media platforms worldwide. The company provides a comprehensive suite of products and services, such as Media Metrix and Mobile Metrix for measuring web and app performance, Video Metrix for tracking digital video consumption alongside TV metrics, and Plan Metrix for consumer lifestyle insights. Additionally, comScore offers validated Campaign Essentials, which ensures the visibility and safety of digital ad impressions, and Campaign Ratings for evaluating cross-platform campaigns. Its offerings also include TV Essentials, StationView Essentials, and OnDemand Essentials for understanding viewing patterns and transactional tracking. Furthermore, the company provides analytics and optimization tools for advertising campaigns and brand protection. comScore's capabilities extend to movie reporting and analytics, delivering insights into box office performance and audience trends. Founded in 1999 and headquartered in Reston, Virginia, comScore serves over 3,200 clients across more than 75 countries, positioning itself as a leader in audience measurement and analytics.
Sensicore
Series B in 2003
Sensicore, Inc. is a manufacturer and developer of smart sensor systems and sensor networks, headquartered in Ann Arbor, Michigan. The company specializes in automating water testing, data collection, and analysis for both drinking and industrial applications. Its flagship products include WaterPOINT, a handheld water tester that provides a comprehensive profile of various chemistry measurements, and WaterNOW, a web-based data visualization and decision support system for managing water systems. Sensicore also offers a variety of sensor kits and bundles designed for disinfection and basic water testing, alongside colorimetric test kits that measure a range of water quality parameters. Additionally, the company provides accessories such as portable thermal printers and power supply products to enhance its testing solutions. Sensicore's products serve multiple applications, including monitoring incoming water quality, cooling tower processes, and filtration system performance. Founded in 2000, Sensicore operates as a subsidiary of GE Analytical Instruments, Inc. as of 2008.
Pionetics
Series B in 2003
Pionetics Corporation is a water technology company based in San Carlos, California, founded in 1995. The company specializes in manufacturing innovative water treatment products designed to produce safe and great-tasting drinking water while minimizing wastewater compared to traditional systems. Pionetics offers a range of products, including water filters, drinking water systems, and water coolers, catering to household, commercial, and industrial applications. In addition to product sales, the company provides installation services and rental options for its drinking water systems. Pionetics distributes its products through authorized dealers both in the United States and internationally. As of 2008, it operates as a subsidiary of Rayne Corporation.
Coastal Security Company
Acquisition in 2002
Coastal was a retail and wholesale security alarm monitoring company. Coastal had a history of consistent growth and low customer attrition and we expected a continuation of its growth profile given its industry and geography.
comScore, Inc. is an information and analytics company that specializes in measuring audiences, consumer behavior, and advertising across various media platforms worldwide. The company provides a comprehensive suite of products and services, such as Media Metrix and Mobile Metrix for measuring web and app performance, Video Metrix for tracking digital video consumption alongside TV metrics, and Plan Metrix for consumer lifestyle insights. Additionally, comScore offers validated Campaign Essentials, which ensures the visibility and safety of digital ad impressions, and Campaign Ratings for evaluating cross-platform campaigns. Its offerings also include TV Essentials, StationView Essentials, and OnDemand Essentials for understanding viewing patterns and transactional tracking. Furthermore, the company provides analytics and optimization tools for advertising campaigns and brand protection. comScore's capabilities extend to movie reporting and analytics, delivering insights into box office performance and audience trends. Founded in 1999 and headquartered in Reston, Virginia, comScore serves over 3,200 clients across more than 75 countries, positioning itself as a leader in audience measurement and analytics.
TeraLogic
Venture Round in 2001
TeraLogic designs integrated circuits, software and platforms for digital TV.
Terk Antennas
Acquisition in 2001
Terk Antennas is a manufacturer and distributor specializing in branded radio and television antennas, along with select components for sound and stereo systems. The company operates as a subsidiary of Audiovox, focusing on delivering high-quality products that enhance audio and visual experiences for consumers. With a commitment to innovation and design, Terk Antennas aims to meet the needs of customers seeking reliable reception solutions for their entertainment systems.